Go to deals
Private Equity | Healthcare | Industrial Machinery & Components

KKR to invest in Precipart Group Ltd.

Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.

Precipart, founded in 1950 by the Laubscher family with roots in Swiss engineering and manufacturing, is a leading contract development and manufacturing organization of highly engineered precision components and assemblies, primarily for the medical device industry as well as the aerospace and industrial markets. Precipart, through its mission to Engineer Possible, is a comprehensive solution provider supporting its customers from the concept phase to serial production and in managing their growing supply chain complexity. Major product offerings include precision machining, micro mechanical components, assemblies, gear systems, motion solutions, technical ceramics and advanced 3D printing.

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people and supporting growth in its portfolio companies and communities. KKR is investing in Precipart through its Health Care Strategic Growth Fund, a fund dedicated to investing in high-growth healthcare-related companies to which KKR can be a unique strategic partner in helping reach scale.

The Laubscher family remains highly committed to Precipart and is retaining a significant minority ownership stake in the company.

Oaklins’ team in Switzerland acted as the exclusive sell-side advisor to the shareholders of Precipart in the transaction. Oaklins TM Capital approached potential investors in the US market and supported the transaction at its early stages.

Parties
“My team, my family and I are thrilled to form this strategic partnership with KKR, who are the right partners to help take Precipart to the next level. The Oaklins team has been instrumental in concluding the transaction with our partner of choice. We have appreciated their high level of commitment, professionalism and guidance through the whole process.”

Oliver Laubscher

Member of the Board and CEO, Precipart Group Ltd.

Talk to the deal team

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland

Jens Rutten

Partner
Zurich, Switzerland
Oaklins Switzerland

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

John Dean

Associate Director
Atlanta, United States
Oaklins TM Capital

Christoph Walker

Associate Director
Zurich, Switzerland
Oaklins Switzerland

Related deals

Lumiforte partners with Kartesia to propel global growth and innovation
Private Equity | Agriculture | Other Industries

Lumiforte partners with Kartesia to propel global growth and innovation

Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.

Learn more
Yxion has been acquired by Normec
Private Equity | Business Support Services

Yxion has been acquired by Normec

Normec has acquired Dutch consultancy Yxion from Antea. Through this acquisition, Normec continues its acquisition strategy in Europe, while also looking for expansion opportunities in the United States.

Learn more
AMC Media Group has been acquired by Formedics
Healthcare | TMT

AMC Media Group has been acquired by Formedics

AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.

Learn more